1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Compounding Pharmacies Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Compounding Pharmacies Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Drug Shortage Crisis Across the World
- 5.1.2 Benefits of Compounded Medications
5.2 Market Opportunities
- 5.2.1 Growing Demand for Compounding Pharmacy During COVID-19
5.3 Future Trends
- 5.3.1 Growing Outsourcing Facilities for Manufacturing and Sales of Products
5.4 Impact of Drivers and Restraints
6. North America Compounding Pharmacies Market Regional Analysis
6.1 North America Compounding Pharmacies Market Overview
6.2 North America Compounding Pharmacies Market Revenue 2019-2028 (US$ Million)
6.3 North America Compounding Pharmacies Market Forecast Analysis
7. North America Compounding Pharmacies Market Analysis – by Product
7.1 Oral Medications
- 7.1.1 Overview
- 7.1.2 Oral Medications: North America Compounding Pharmacies Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Topical Medications
- 7.2.1 Overview
- 7.2.2 Topical Medications: North America Compounding Pharmacies Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Suppositories
- 7.3.1 Overview
- 7.3.2 Suppositories: North America Compounding Pharmacies Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Compounding Pharmacies Market Analysis – by Therapeutic Area
8.1 Pain Medications
- 8.1.1 Overview
- 8.1.2 Pain Medications: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Hormone Replacement Therapies
- 8.2.1 Overview
- 8.2.2 Hormone Replacement Therapies: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Dermatological Applications
- 8.3.1 Overview
- 8.3.2 Dermatological Applications: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Compounding Pharmacies Market – North America Analysis
9.1 North America
- 9.1.1 North America Compounding Pharmacies Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 9.1.1.1 North America Compounding Pharmacies Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 US:
North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.1.1 US: North America Compounding Pharmacies Market Breakdown, by Product
- 9.1.1.1.2 US: North America Compounding Pharmacies Market Breakdown, by Therapeutic Area
- 9.1.1.2 Canada:
North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.2.1 Canada: North America Compounding Pharmacies Market Breakdown, by Product
- 9.1.1.2.2 Canada: North America Compounding Pharmacies Market Breakdown, by Therapeutic Area
- 9.1.1.3 Mexico :
North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.3.1 Mexico : North America Compounding Pharmacies Market Breakdown, by Product
- 9.1.1.3.2 Mexico : North America Compounding Pharmacies Market Breakdown, by Therapeutic Area
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. North America Compounding Pharmacies Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Avella specialty pharmacy
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 B.Braun Melsungen AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Fagron, Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Fresenius Kabi AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 PharMEDium Healthcare Holdings, Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Triangle Compounding Pharmacy
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 US Compounding Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Vertisis Custom Pharmacy
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For North America Compounding Pharmacies Market
